Search Page

1

Cite

Share

Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs.

Van den Anker JN, McCune S, Annaert P, Baer GR, Mulugeta Y, Abdelrahman R, Wu K, Krudys KM, Fisher J, Slikker W, Chen C, Burckart GJ, Allegaert K. Van den Anker JN, et al. Pharmaceutics. 2020 Jul 20;12(7):685. doi: 10.3390/pharmaceutics12070685. Pharmaceutics. 2020. PMID: 32698409 Free PMC article.

Cite

Share

2

Cite

Share

Retrospective drug utilization review of meropenem and role of infectious disease pharmacist in specialized cancer care hospital.

Khan MR, Saleem Z, Batool N, Babar M, Shabbir A. Khan MR, et al. J Oncol Pharm Pract. 2022 Jun;28(4):910-915. doi: 10.1177/10781552221077929. Epub 2022 Mar 7. J Oncol Pharm Pract. 2022. PMID: 35253504

Cite

Share

3

Cite

Share

Prevention and treatment of neonatal nosocomial infections.

Ramasethu J. Ramasethu J. Matern Health Neonatol Perinatol. 2017 Feb 13;3:5. doi: 10.1186/s40748-017-0043-3. eCollection 2017. Matern Health Neonatol Perinatol. 2017. PMID: 28228969 Free PMC article. Review.

Cite

Share

4

Cite

Share

Editorial commentary: effectiveness or efficacy: which study to evaluate antibiotics in neonates?

Jacqz-Aigrain E. Jacqz-Aigrain E. Clin Infect Dis. 2012 Dec;55(11):1503-4. doi: 10.1093/cid/cis767. Epub 2012 Sep 5. Clin Infect Dis. 2012. PMID: 22955433 No abstract available.

Cite

Share

5

Cite

Share

Dosing in neonates: special considerations in physiology and trial design.

Ku LC, Smith PB. Ku LC, et al. Pediatr Res. 2015 Jan;77(1-1):2-9. doi: 10.1038/pr.2014.143. Epub 2014 Sep 30. Pediatr Res. 2015. PMID: 25268145 Free PMC article. Review.

Cite

Share

6

Cite

Share

Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial.

Lutsar I, Chazallon C, Trafojer U, de Cabre VM, Auriti C, Bertaina C, Calo Carducci FI, Canpolat FE, Esposito S, Fournier I, Hallik M, Heath PT, Ilmoja ML, Iosifidis E, Kuznetsova J, Meyer L, Metsvaht T, Mitsiakos G, Pana ZD, Mosca F, Pugni L, Roilides E, Rossi P, Sarafidis K, Sanchez L, Sharland M, Usonis V, Warris A, Aboulker JP, Giaquinto C; NeoMero Consortium. Lutsar I, et al. PLoS One. 2020 Mar 4;15(3):e0229380. doi: 10.1371/journal.pone.0229380. eCollection 2020. PLoS One. 2020. PMID: 32130261 Free PMC article. Clinical Trial.

Cite

Share

7

Cite

Share

Drugs for the Prevention and Treatment of Sepsis in the Newborn.

Mukhopadhyay S, Wade KC, Puopolo KM. Mukhopadhyay S, et al. Clin Perinatol. 2019 Jun;46(2):327-347. doi: 10.1016/j.clp.2019.02.012. Epub 2019 Mar 30. Clin Perinatol. 2019. PMID: 31010563 Free PMC article. Review.

Cite

Share

8

Cite

Share

Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants.

Hornik CP, Herring AH, Benjamin DK Jr, Capparelli EV, Kearns GL, van den Anker J, Cohen-Wolkowiez M, Clark RH, Smith PB; Best Pharmaceuticals for Children Act-Pediatric Trials Network. Hornik CP, et al. Pediatr Infect Dis J. 2013 Jul;32(7):748-53. doi: 10.1097/INF.0b013e31828be70b. Pediatr Infect Dis J. 2013. PMID: 23838776 Free PMC article.

Cite

Share

9

Cite

Share

How to optimize the evaluation and use of antibiotics in neonates.

van den Anker JN. van den Anker JN. Early Hum Dev. 2014 Mar;90 Suppl 1:S10-2. doi: 10.1016/S0378-3782(14)70004-0. Early Hum Dev. 2014. PMID: 24709446 Review.

Cite

Share

10

Cite

Share

Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.

Aguilera-Alonso D, Escosa-García L, Saavedra-Lozano J, Cercenado E, Baquero-Artigao F. Aguilera-Alonso D, et al. Antimicrob Agents Chemother. 2020 Feb 21;64(3):e02183-19. doi: 10.1128/AAC.02183-19. Print 2020 Feb 21. Antimicrob Agents Chemother. 2020. PMID: 31844014 Free PMC article. Review.

Cite

Share